October 13, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for October 29, 2005 Subscribe to this News Feed  
 

Author Of Autism Paper Linking Augmentin Use To Increased Incidence Of Autism Welcomes Overwhelming Response From Parents Whose Children Experienced Regressive Autism

Download this press release as an Adobe PDF document.

The author of the seminal paper: Could one of the most widely prescribed antibiotics amoxicillin/clavulanate “AUGMENTIN” be a risk factor for autism? published in Medical Hypotheses January 2005 (64, 312-315) has received thousands of emails, letters and phone calls from parents of children who experienced regressive autism following one or more dosages of Augmentin (amoxicillin/clavulanate).

(PRWEB) October 29, 2005 -- The author of the seminal paper: Could one of the most widely prescribed antibiotics amoxicillin/clavulanate “AUGMENTIN” be a risk factor for autism? published in Medical Hypotheses January 2005 (64, 312-315) has received thousands of emails, letters and phone calls from parents of children who experienced regressive autism following one or more dosages of Augmentin (amoxicillin/clavulanate).

Dr. Joan Fallon reports in an interview conducted recently that since the publication of her paper she has received more than 2300 unsolicited emails, letters or phone calls from parents whose children they felt had experienced regressive autism as a result of taking the antibiotic augmentin (amoxicillin/clavulanate). “When the paper was published, I never dreamt that the level of response would be so great,” states Fallon. “I thought for sure there was a linkage, and indeed the subject needs to be further examined, and research needs to be done in this area,” according to Fallon.

In her paper, the author proposed a mechanism whereby children who received the antibiotic may develop autism as a result of the urea/ammonia toxicity in the gastrointestinal tract. She further links the introduction of augmentin in the early 1980’s for the use in children with otitis media, and the large numbers of children who have autism with protracted ear infections.

“It is imperative that further research be undertaken to determine if a subset of children are at risk for neurotoxicity due to the use of clavulanic acid in pharmaceutical preparations,” the paper states in it’s conclusion. “Looking into the potential multifactorial etiologies surrounding autism is an important next step in discovering a potential cure for autism,” said Fallon

For further information please contact Ricardo Felto of LFH Media.

###


See the original story at: http://www.prweb.com/releases/2005/10/prweb302899.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Ricardo Felto
LFH MEDIA
914-879-5084
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright